Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist, and Executive Director of Employer Services at the City of Hope Comprehensive Cancer Center in Duarte, CA.

Our Next Webinar: Dr. Dara Aisner on Molecular Pathology in Lung Cancer
Sat, 07/21/2012 - 11:42
Howard (Jack) West, MD, Associate Clinical Professor, Medical Oncology, Executive Director, Employer Services, Founder, President and CEO of GRACE

Folks here know that just about every day we discuss questions of what molecular marker test to order for lung cancer, how important it is, how it's done, what tissue is needed, and other very timely and practical issues in lung cancer.  These are questions that evolve every few months, as new research emerges with different markers.  

Who is doing this work? People like Dr. Dara Aisner, Co-Director of the Colorado Molecular Correlates Laboratory and Assistant Professor in the Department of Pathology at the University of Colorado.  Yes, that's the same University of Colorado lab that we're always talking about here as representing the absolute leading edge of molecular oncology, one of the very first labs on the planet to do ALK testing and now ROS1 testing, and among the most integral participants in the Lung Cancer Molecular Consortium.  

We're lucky enough to have Dr. Aisner join me on Wednesday, August 22nd at 7 PM Eastern/4 PM Pacific to discuss a broad range of important issues in pathology and molecular diagnostics, ranging from how we get from a biopsy to a marker result, what the current limitations are, how to overcome those barriers, and what the emerging future of molecular oncology looks like.  Sounds very interesting, right?

So join us for this program, co-sponsored with LUNGevity Foundation.  We'll have the audio and video versions of the webinar online, along with the transcript and figures, but you'll want to be there for the live program, with time for your own questions, if you can.  You can also feel free to get a jump on things by suggesting some questions here as a comment.

 Just click here for free registration. I think this webinar will be of great interest to lots of you.


Next Previous link

Previous PostNext Post

Related Content

Mandarin LCVL
王林医生用普通话讨论重要的肺癌信息。这些信息包括靶向治疗、晚期疾病的症状、循环肿瘤 DNA、治疗方案等。我们鼓励您与社区中说普通话的人分享。 Dr. Lin Wang discusses important lung cancer information in Mandarin. This information includes targeted therapy, symptoms of advanced disease, circulating tumor DNA, treatment options, and more. We encourage you to share this with the Mandarin speakers in your community. To watch the complete Playlist visit:…;  
Tell your story!  Apply now for the Clinical Trials Experiences through Storytelling Program
We are excited to launch our third year of this program; tell your story and help us help others! Apply Online Now!     GRACE Patient Perspectives: Clinical Trials Experiences Storytelling Program Overview  
Blood Cancer OncTalk
Blood Cancer OncTalk was a live presentation that brought together top oncologists to discuss emerging concepts and treatment options in blood cancer. The program was chaired by Dr. Aaron Goodman, with the participation of Dr. Mazie Tsang, Hematologist / Oncologist; Dr. Autumn Jeong, Hematologist / Oncologist; Dr. Shaji Kumar, Hematologist / Oncologist; and Dr. Sridevi Rajeeve, Hematologist / Oncologist.

Forum Discussions

Hi Caregiver and welcome to Grace.  I'm sorry that you need to be here and hope we can help.  Osimertinib has better efficacy than gefitinib (including OS and reaching the brain)...

Hi Bob, Welcome to Grace.  I'm sorry about your sil.  Unfortunately, cancer becomes resistant to TKIs like tagrisso.  Sometimes all of the cancer becomes resistant at once and sometimes just parts...

Recent Comments

Hi Tammy,  Welome to Grace. …
By JanineT GRACE … on Tue, 05/16/2023 - 13:44
By Tndiuka10 on Fri, 05/12/2023 - 21:13
Hi Caregiver and welcome to…
By JanineT GRACE … on Fri, 05/12/2023 - 14:20
Hi Bob, Welcome to Grace.  I…
By JanineT GRACE … on Tue, 05/02/2023 - 12:29